======= LEPREL1 =======
== Gene Information ==
* **Official Symbol**: P3H2
* **Official Name**: prolyl 3-hydroxylase 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55214|55214]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8IVL5|Q8IVL5]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=LEPREL1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LEPREL1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/610341|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the prolyl 3-hydroxylase subfamily of 2-oxo-glutarate-dependent dioxygenases. These enzymes play a critical role in collagen chain assembly, stability and cross-linking by catalyzing post-translational 3-hydroxylation of proline residues. Mutations in this gene are associated with nonsyndromic severe myopia with cataract and vitreoretinal degeneration, and downregulation of this gene may play a role in breast cancer. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011].
* **UniProt Summary**: Prolyl 3-hydroxylase that catalyzes the post- translational formation of 3-hydroxyproline on collagens (PubMed:18487197). Contributes to proline 3-hydroxylation of collagen COL4A1 and COL1A1 in tendons, the eye sclera and in the eye lens capsule (By similarity). Has high activity with the type IV collagen COL4A1, and lower activity with COL1A1 (PubMed:18487197). Catalyzes hydroxylation of the first Pro in Gly-Pro-Hyp sequences where Hyp is 4-hydroxyproline (PubMed:18487197). Has no activity on substrates that lack 4- hydroxyproline in the third position (PubMed:18487197). {ECO:0000250|UniProtKB:Q8CG71, ECO:0000269|PubMed:18487197}.
No Pfam Domain information is available for this gene.
|procollagen-proline 3-dioxygenase activity|
|peptidyl-proline hydroxylation|
|L-ascorbic acid binding|
|protein hydroxylation|
|sarcoplasmic reticulum|
|peptidyl-proline modification|
|collagen metabolic process|
|basement membrane|
|iron ion binding|
|endoplasmic reticulum lumen|
|negative regulation of cell population proliferation|
|peptidyl-amino acid modification|
|oxidation-reduction process|
|Golgi apparatus|
|endoplasmic reticulum|
|regulation of cell population proliferation|
\\
=== CRISPR Data ===
No hits were found.
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 6867
* **Expression level (log2 read counts)**: 0.75
{{:chemogenomics:nalm6 dist.png?nolink |}}